Fig. 6.
MTAP is a protein target for the IPL ligand Pro-AP1780. (A) Validation with Western blot analysis of MTAP in IPL pull-downs and cell lysate. (B) In vitro MTAP activity assay with 3 dose levels of each IPL ligand. All IPL ligands show slight inhibition of MTAP at the highest levels of compound dose (850 μM). Pro-AP1780 shows the largest inhibitory effect on MTAP in comparison with DMSO treated controls.